Does cancer-associated thrombosis prevention benefit from a multidisciplinary approach?

Does cancer-associated thrombosis prevention benefit from a multidisciplinary approach?

 

 

Thrombosis is the second cause of death in cancer patients after cancer itself.  Both arterial and venous thromboembolism are common complications of cancer, and increase the thrombosis risk by 20% on average, depending on the tumour type and site. Causes are due to the actual treatment of cancer (chemo and radiotherapies), surgery, some maneuvers  and cancer itself.  The need of close collaboration among different specialists to prevent and treat such events has been widely acknowledged in the past years.

Dr Benjamin Brenner, Rambam Medical Center, Haifa, Israel, explains what has been achieved thanks to such meetings as ICTHIC. 

Rate this article

Login or register to leave a comment or rate this article


Register